NMNAT2 and ovarian carcinoma: Ovarian cancer was also shown to markedly upregulate NMNAT2 expression to enhance NAD+ formation and thereby promote the NAD+-dependent mono ADP-ribosylation (MAR) of ribosomal proteins through the catalytic activity of PARP-16 [115,116].